SCHEMBL9775108

SCHEMBL9775108

O=C(CCSCc1ccccc1)c1ccc(F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.60
▸ NPC1 O15118 2/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ HSD11B1 P28845 2/20 0.50
▸ TP53 P04637 2/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ LMNA P02545 3/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ L3MBTL1 Q9Y468 3/20 0.47
▸ TAAR1 Q96RJ0 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47
▸ HTR7 P34969 1/20 0.46
▸ MAPT P10636 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ ALDH1A1 P00352 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8014835 0.84 LMNA (0.53) CYP2C19NPC1RAB9AHSD11B1TP53
SCHEMBL11158191 0.80 CYP2C19 (0.58) CYP2C19RAB9ATP53KMT2ALMNA
SCHEMBL23232300 0.78 CYP2C19 (0.70) CYP2C19NPC1RAB9ATP53KMT2A
SCHEMBL28012695 0.78 NPC1 (0.65) NPC1RAB9AHSD11B1LMNAL3MBTL1
SCHEMBL28197598 0.78 NPC1 (0.84) NPC1RAB9AHSD11B1MEN1KMT2A
SCHEMBL29275329 0.78 NPC1 (0.55) CYP2C19NPC1RAB9AHSD11B1MEN1
SCHEMBL8014833 0.78 ALDH1A1 (0.56) NPC1RAB9ATP53KMT2ALMNA
SCHEMBL4485908 0.77 RAB9A (0.69) CYP2C19NPC1RAB9AHSD11B1MEN1
SCHEMBL9622180 0.76 CYP2C19 (0.62) CYP2C19NPC1RAB9ATP53MEN1
SCHEMBL44801 0.76 CYP2C19 (1.00) CYP2C19TP53KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5075339-A Antiinflammatory agents, antiallergens DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1991-12-24 — — US disclosed
US-4948813-A Benzylketone phospholipase A2 inhibitors E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-08-14 — — US disclosed
Send feedback